Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yoshio Marumoto"'
Autor:
Michiko Itoh, Hideaki Kato, Takayoshi Suganami, Kuniha Konuma, Yoshio Marumoto, Shuji Terai, Hiroshi Sakugawa, Sayaka Kanai, Miho Hamaguchi, Takahiro Fukaishi, Seiichiro Aoe, Kazunari Akiyoshi, Yoshihiro Komohara, Motohiro Takeya, Isao Sakaida, Yoshihiro Ogawa
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82163 (2013)
Although macrophages are thought to be crucial for the pathogenesis of chronic inflammatory diseases, how they are involved in disease progression from simple steatosis to non-alcoholic steatohepatitis (NASH) is poorly understood. Here we report the
Externí odkaz:
https://doaj.org/article/06af7bc8550341ae8b22971a2e7e4a36
Autor:
Ryuta ASADA, Masahiko ICHIMURA, Akiko IMAI, Kanae IWATA, Yuki OHTA, Kayoko KIKUCHI, Koichi KONNO, Yoshiko TAKAGI, Tomoko TERADA, Naoko HAGIMORI, Erika HORIBE, Yoshio MARUMOTO
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 54:85-88
Autor:
Yurika Yamauchi, Issei Saeki, Takahiro Yamasaki, Maho Egusa, Natsuko Nishiyama, Tsuyoshi Fujioka, Daiki Kawamoto, Tatsuro Nishimura, Norikazu Tanabe, Takashi Oono, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Yoshio Marumoto, Satoshi Matsukuma, Yoshitaro Shindo, Yukio Tokumitsu, Sota Yoshimine, Junichi Murakami, Toshiki Tanaka, Sotai Kimura, Yoshinobu Hoshii, Kimikazu Hamano, Hiroaki Nagano, Taro Takami
Publikováno v:
Hepatology Research.
Autor:
Takashi Oono, Reo Kawano, Isao Hidaka, Tsuyoshi Ishikawa, Takahiro Yamasaki, Miyuki Masui, Toshihiko Matsumoto, Aki Fujinaga, Takuro Hisanaga, Taro Takami, Isao Sakaida, Issei Saeki, Yoshio Marumoto
Publikováno v:
Kanzo. 62:448-455
Autor:
Toshihiko Matsumoto, Takuro Hisanaga, Taro Takami, Issei Saeki, Takahiro Yamasaki, Yoshio Marumoto, Yutaka Suehiro, Isao Hidaka, Tsuyoshi Ishikawa, Isao Sakaida, Naoki Yamamoto, Takuya Iwamoto, Masaki Maeda, Koichi Fujisawa
Publikováno v:
World Journal of Hepatology. 10:571-584
Sorafenib is used worldwide as a first-line standard systemic agent for advanced hepatocellular carcinoma (HCC) on the basis of the results of two large-scale Phase III trials. Conversely, hepatic arterial infusion chemotherapy (HAIC) is one of the m
Autor:
Toshihiko Matsumoto, Yoshio Marumoto, Takuro Hisanaga, Isao Sakaida, Taro Takami, Takuya Iwamoto, Isao Hidaka, Issei Saeki, Tsuyoshi Ishikawa, Masaki Maeda, Takahiro Yamasaki
Publikováno v:
Yamaguchi Medical Journal. 66:163-168
Autor:
Issei, Saeki, Takahiro, Yamasaki, Masaki, Maeda, Takuro, Hisanaga, Takuya, Iwamoto, Koichi, Fujisawa, Toshihiko, Matsumoto, Isao, Hidaka, Yoshio, Marumoto, Tsuyoshi, Ishikawa, Naoki, Yamamoto, Yutaka, Suehiro, Taro, Takami, Isao, Sakaida
Publikováno v:
World Journal of Hepatology
Sorafenib is used worldwide as a first-line standard systemic agent for advanced hepatocellular carcinoma (HCC) on the basis of the results of two large-scale Phase III trials. Conversely, hepatic arterial infusion chemotherapy (HAIC) is one of the m
Autor:
Issei Saeki, Takuya Iwamoto, Ichiro Kunitugu, Tsuyoshi Tanabe, Takahiro Yamasaki, Junichi Zaitsu, Isao Sakaida, Koichi Uchida, Makoto Segawa, Isao Hidaka, Yumiko Harima, Takashi Oono, Yoshio Marumoto, Taro Takami, Yohei Urata, Shuji Terai, Tsuyoshi Ishikawa
Publikováno v:
Hepatology Research. 44:E54-E62
Aim Insulin resistance (IR) increases during the early stages of hepatitis C virus (HCV)-related chronic liver disease and is a sign of poor prognosis as well as a risk factor for hepatic fibrosis and hepatocellular carcinoma. We aimed to determine t
Autor:
Seiji Kaino, Shuji Terai, Tsuyoshi Ishikawa, Naoki Yamamoto, Isao Sakaida, Yoshio Marumoto, Toshihiko Matsumoto, Takuya Iwamoto, Yohei Urata, Taro Takami, Yohei Harima, Isao Hidaka, Issei Saeki, Koichi Uchida, Takahiro Yamasaki, Yumiko Harima, Junichi Zaitsu
Publikováno v:
Hepatology Research. 44:481-490
Aim We recently reported that the iron chelator deferoxamine (DFO) is efficacious in advanced hepatocellular carcinoma (HCC) patients. Iron regulation may thus have an important impact in HCC therapy. Because transferrin is a native chelator that reg
Autor:
Yuko Mizunaga, Koh Shinoda, Naoki Yamamoto, Tomoaki Murata, Yoshio Marumoto, Koji Aoyama, Yohei Urata, Isao Sakaida, Shuji Terai, Tsuyoshi Ishikawa, Hiroshi Nishina
Publikováno v:
Cell and Tissue Research. 327:463-470
We previously reported that fibroblast growth factor 2 (FGF2) facilitated the differentiation of transplanted bone marrow cells (BMCs) into hepatocytes. Our earlier study also demonstrated that administration of FGF2 in combination with bone marrow t